PTGS2 and neoplasm: Significantly, inhibition of these non-COX-2 targets by celecoxib also seems to occur in animal tumour models in vivo, arguing against earlier concerns that such effects might be artefacts of the high drug concentrations used in cell culture systems in vitro.